acusurgical

Founded in 2020, AcuSurgical is a surgical robotics company based in Montpellier (France). AcuSurgical's mission is to enable top-class treatment to the 300+ million patients suffering from retinal disease worldwide.  Retinal disease has a huge impact on the quality of life of mostly elderly patients, with 1 in 3 europeans over 70  affected by these debilitating conditions including age-related macular degeneration (AMD), diabetic retinopathy and macular holes. Worldwide, currently 1.6 million retinal surgeries are performed each year, with a yearly growth rate of 7%. This currently represents only a small percentage of actual cases, with the majority of patients, especially in emerging economies, getting inadequate treatment or often no treatment at all. The cutting-edge robotics platform from AcuSurgical aims to change this, bringing a new surgical paradigm to vitreoretinal surgery based on precision robotics.

The company develops a robotic assistant that provides greater precision for retinal microsurgery (10 μm instead of 100 μm for the surgeon’s hand), which are very delicate procedures requiring highly precise treatments. The Luca™ system allows surgeons to treat more patients, address a wider range of pathologies, expedite training, and increase accuracy and safety. It is composed of 2 arms with an instrument holder at each end that will be piloted by the surgeon via a console. Unlike other solutions, the robot adapts to the patient's position thanks to its digital RCM (Remote Center of Motion). AcuSurgical's innovative robotic platform also aims to bring a new paradigm in subretinal injections for cell and gene therapies with a precision robotic solution.

Acusurgical, July 7th 2024, has announced the successful completion of its first clinical study involving the world’s first dual-instrument ophthalmic surgical system. This study evaluated the Luca™ surgical robot for vitrectomy procedures, marking a significant milestone in introducing this groundbreaking technology to hospitals with the potential to improve care for millions of patients with retinal issues.

This successful clinical study marks a significant advancement for Acusurgical in enhancing retinal surgery through innovative technology.